Swipe om te navigeren naar een ander artikel
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Aman, M. G., Lam, K. S., & Collier-Crespin, A. (2003). Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders, 33(5), 527–534. CrossRef
Aman, M. G., Lam, K. S., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child & Adolescent Psychopharmacology, 15(1), 116–126. CrossRef
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Philadelphia: American Psychiatric Publishing, Inc. CrossRef
Bakken, T. L., Helverschou, S. B., Eilertsen, D. E., Heggelund, T., Myrbakk, E., & Martinsen, H. (2010). Psychiatric disorders in adolescents and adults with autism and intellectual disability: A representative study in one county in Norway. Research in Developmental Disabilities, 31(6), 1669–1677. CrossRef
Bradley, E. A., Summers, J. A., Wood, H. L., & Bryson, S. E. (2004). Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism. Journal of Autism and Developmental Disorders, 34(2), 151–161. CrossRef
Brereton, A. V., Tonge, B. J., & Einfeld, S. L. (2006). Psychopathology in children and adolescents with autism compared to young people with intellectual disability. Journal of Autism and Developmental Disorders, 36(7), 863–870. CrossRef
Buck, T. R., Viskochil, J., Farley, M., Coon, H., McMahon, W. M., Morgan, J., & Bilder, D. A. (2014). Psychiatric comorbidity and medication use in adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(12), 3063–3071. CrossRef
Cooper, S. A., Smiley, E., Morrison, J., Williamson, A., & Allan, L. (2007). Mental ill-health in adults with intellectual disabilities: Prevalence and associated factors. The British Journal of Psychiatry, 190(1), 27–35. CrossRef
Crocker, A. G., Prokić, A., Morin, D., & Reyes, A. (2014). Intellectual disability and co-occurring mental health and physical disorders in aggressive behaviour. Journal of Intellectual Disability Research, 58(11), 1032–1044. CrossRef
Deb, S., Unwin, G., & Deb, T. (2015). Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Journal of Intellectual Disability Research, 59(1), 11–25. CrossRef
Doan, T. N., Lennox, N. G., Taylor-Gomez, M., & Ware, R. S. (2013). Medication use among Australian adults with intellectual disability in primary healthcare settings: A cross-sectional study. Journal of Intellectual and Developmental Disability, 38(2), 177–181. CrossRef
Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A., & Veenstra-VanderWeele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, peds-2012.
Einfeld, S. L., Ellis, L. A., & Emerson, E. (2011). Comorbidity of intellectual disability and mental disorder in children and adolescents: A systematic review. Journal of Intellectual and Developmental Disability, 36(2), 137–143. CrossRef
Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., … Hatton, C. (2001). The prevalence of challenging behaviors: A total population study. Research in Developmental Disabilities, 22(1), 77–93.
Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(9), 1339–1349. CrossRef
Frazier, T. W., Shattuck, P. T., Narendorf, S. C., Cooper, B. P., Wagner, M., & Spitznagel, E. L. (2011). Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21(6), 571–579. CrossRef
Hewitt, A. S., Stancliffe, R., Hall-Lande, J., Nord, D., Pettingell, S., Hamre, K., & Hallas-Muchow, E. (2017). Characteristics of adults with autism spectrum disorder who use residential services and supports through adult developmental disabilities in the United States. Research in Autism Spectrum Disorders, 34, 1–9. CrossRef
Hofvander, B., Delorme, R., Chaste, P., Nydén, A., Wentz, E., Ståhlberg, O., … Råstam, M. (2009). Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry, 9(1), 35.
Holden, B., & Gitlesen, J. P. (2004). Psychotropic medication in adults with mental retardation: Prevalence, and prescription practices. Research in Developmental Disabilities, 25(6), 509–521. CrossRef
Holden, B., & Gitlesen, J. P. (2006). A total population study of challenging behaviour in the county of Hedmark, Norway: Prevalence, and risk markers. Research in Developmental Disabilities, 27(4), 456–465. CrossRef
Horner, R. H., Carr, E. G., Strain, P. S., Todd, A. W., & Reed, H. K. (2002). Problem behavior interventions for young children with autism: A research synthesis. Journal of Autism and Developmental Disorders, 32(5), 423–446. CrossRef
HSRI and NADDDS. (2014). 2012–2013 ACS Final Report. Retrieved from http://www.nationalcoreindicators.org/upload/core-indicators/FINAL2012- 13_ACS_Final_Report_2.pdf.
Hutton, J., Goode, S., Murphy, M., Le Couteur, A., & Rutter, M. (2008). New-onset psychiatric disorders in individuals with autism. Autism, 12(4), 373–390. CrossRef
Joshi, G., Biederman, J., Petty, C., Goldin, R. L., Furtak, S. L., & Wozniak, J. (2013). Examining the comorbidity of bipolar disorder and autism spectrum disorders: A large controlled analysis of phenotypic and familial correlates in a referred population of youth with bipolar I disorder with and without autism spectrum disorders. The Journal of Clinical Psychiatry, 74(6), 578–586. CrossRef
Kats, D., Payne, L., Parlier, M., & Piven, J. (2013). Prevalence of selected clinical problems in older adults with autism and intellectual disability. Journal of Neurodevelopmental Disorders, 5(1), 27. CrossRef
Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12(4), 311–321. CrossRef
Matson, J. L., & Rivet, T. T. (2008). Characteristics of challenging behaviours in adults with autistic disorder, PDD-NOS, and intellectual disability. Journal of Intellectual and Developmental Disability, 33(4), 323–329. CrossRef
McCarthy, J., Hemmings, C., Kravariti, E., Dworzynski, K., Holt, G., Bouras, N., & Tsakanikos, E. (2010). Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders. Research in Developmental Disabilities, 31(2), 362–366. CrossRef
Mohiuddin, S., & Ghaziuddin, M. (2013). Psychopharmacology of autism spectrum disorders: A selective review. Autism, 17(6), 645–654. CrossRef
Morgan, C. N., Roy, M., & Chance, P. (2003). Psychiatric comorbidity and medication use in autism: A community survey. The Psychiatrist, 27(10), 378–381.
Morgan, V. A., Leonard, H., Bourke, J., & Jablensky, A. (2008). Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. The British Journal of Psychiatry, 193(5), 364–372. CrossRef
Murphy, G. H., Beadle-Brown, J., Wing, L., Gould, J., Shah, A., & Holmes, N. (2005). Chronicity of challenging behaviours in people with severe intellectual disabilities and/or autism: A total population sample. Journal of Autism and Developmental Disorders, 35(4), 405–418 CrossRef
National Association of State Mental Health Program Directors, Medical Directors Council and State Medicaid Directors (2001). NASMHPD Medical Directors’ Technical Report on Psychiatric Polypharmacy. Alexandria, VA.
National Core Indicators (NCI). (2011). What does NCI tell us about people with dual diagnosis? NCI Data Brief, 2, 1–8. Retrieved from https://www.nationalcoreindicators.org/upload/core-indicators/Data_Brief_--_dual_dx_--_Issue_2_--_April_4_2011_1.pdf.
National Institute for Health and Clinical Excellence, UK [NICE]. (2012). Autism: Recognition, referral, diagnosis and management of adults on the autism spectrum. Clinical Guideline, 142, 18–19 http://guidance.nice.org.uk/cg142.
Posey, D. J., Erickson, C. A., Stigler, K. A., & McDougle, C. J. (2006). The use of selective serotonin reuptake inhibitors in autism and related disorders. Journal of Child & Adolescent Psychopharmacology, 16(1–2), 181–186. CrossRef
Rao, J. N. K., & Scott, A. J. (1984). On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Annals of Statistics, 12, 46–60. CrossRef
Sawyer, A., Lake, J. K., Lunsky, Y., Liu, S. K., & Desarkar, P. (2014). Psychopharmacological treatment of challenging behaviours in adults with autism and intellectual disabilities: A systematic review. Research in Autism Spectrum Disorders, 8(7), 803–813. CrossRef
Shattuck, P. T., Seltzer, M. M., Greenberg, J. S., Orsmond, G. I., Bolt, D., Kring, S., & Lord, C. (2007). Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder. Journal of Autism and Developmental Disorders, 37(9), 1735–1747. CrossRef
Siegel, M. (2018). The severe end of the spectrum: Insights and opportunities from the autism inpatient collection (AIC). Journal of Autism and Developmental Disorders, 48, 3641–3646. CrossRef
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child & Adolescent Psychiatry, 47(8), 921–929. CrossRef
Smith, K. R., & Matson, J. L. (2010a). Psychopathology: Differences among adults with intellectually disabled, comorbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 31(3), 743–749. CrossRef
Smith, K. R., & Matson, J. L. (2010b). Behavior problems: Differences among intellectually disabled adults with co-morbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 31(5), 1062–1069. CrossRef
Spencer, D., Marshall, J., Post, B., Kulakodlu, M., Newschaffer, C., Dennen, T., … Jain, A. (2013). Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics, 132(5), 833–840.
StataCorp. (2013a). Stata Statistical Software: Release 2013. College Station: StataCorp LP.
StataCorp. (2013b). Stata survey data reference manual: Release 13. College Station, TX: Stata Press.
Stolker, J. J., Heerdink, E. R., Leufkens, H. G., Clerkx, M. G., & Nolen, W. A. (2001). Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders. General Hospital Psychiatry, 23(6), 345–349. CrossRef
Totsika, V., Hastings, R. P., Emerson, E., Lancaster, G. A., & Berridge, D. M. (2011). A population-based investigation of behavioural and emotional problems and maternal mental health: Associations with autism spectrum disorder and intellectual disability. Journal of Child Psychology and Psychiatry, 52(1), 91–99. CrossRef
Tsakanikos, E., Costello, H., Holt, G., Bouras, N., Sturmey, P., & Newton, T. (2006). Psychopathology in adults with autism and intellectual disability. Journal of Autism and Developmental Disorders, 36(8), 1123–1129. CrossRef
Tsiouris, J. A., Kim, S. Y., Brown, W. T., & Cohen, I. L. (2011). Association of aggressive behaviours with psychiatric disorders, age, sex and degree of intellectual disability: a large-scale survey. Journal of Intellectual Disability Research, 55(7), 636–649. CrossRef
- Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States
Sandra L. Pettingell
- Springer US
Journal of Autism and Developmental Disorders
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432